349 results on '"Ono, Makiko"'
Search Results
2. The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin
3. Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
4. A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients
5. HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
6. Appearance-Related Needs and Challenges Among Cancer Patients Undergoing Systemic Therapy: A Comprehensive Survey Study
7. Enfortumab vedotin (EV) in triple-negative breast cancer (TNBC) and HR+/HER2- breast cancer (BC) cohorts of EV-202.
8. Outcomes in Nonmetastatic Hormone Receptor–Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study
9. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
10. A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer
11. A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors
12. Reconstruction of Holocene Optimum paleoclimatic variations using long-chain n-alkanes and alkenones in sediments from Dabusu Lake, northeastern China
13. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib
14. Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma
15. Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer
16. SY06-2 Treatment and survivorship for premenopausal women with breast cancer
17. Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report
18. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index
19. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
20. First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part
21. Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study
22. Abstract P3-05-36: Prognostic factors in non-metastatic hormone receptor-positive HER2-negative mucinous breast cancer: an international multicentre cohort study
23. Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series
24. Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
25. Breast Cancer Stem Cell: Translating to the Clinic
26. Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging
27. Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma
28. Light intensity modulates antioxidant systems in salt-stressed tomato (Solanum lycopersicum L. cv. Micro-Tom) fruits
29. Exosomal tumor-suppressive microRNAs as novel cancer therapy: “Exocure” is another choice for cancer treatment
30. Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers
31. Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort
32. Additional file 1 of HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
33. Assessment of Pazopanib-Related Heart Failure in Patients With Advanced Soft Tissue Sarcoma ― A Single Institute Analysis ―
34. Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
35. Abstract OT1-02-04: Enfortumab vedotin 202: Phase 2 study of enfortumab vedotin for previously treated advanced solid tumors, including breast cancer
36. Abstract OT1-18-01: A randomized controlled phase III study of bevacizumab and paclitaxel in combination with atezolizumab as a treatment for patients with locally advanced or metastatic hormone receptor-positive HER2 negative breast cancer: JCOG1919E/AMBITION study
37. Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin vs. Those with Extremities/Trunk Origin
38. O1-7-5 - Incidence and risk factors of interstitial lung disease (ILD) of head and neck cancer patients treated with Cetuximab
39. Drug-induced gingival overgrowth and its tentative pharmacotherapy
40. Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
41. Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
42. The expression and clinical significance of ribophorin II (RPN2) in human breast cancer
43. Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma
44. Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor
45. Association Between Cancer Cachexia and Prognosis in Patients with Head and Neck Squamous Cell Carcinoma Who Received Chemoradiotherapy
46. P20-2 Comparison of triweekly cisplatin regimens in adjuvant chemoradiotherapy for locally advanced head and neck cancer
47. P46-2 A case of cancer-associated dermatomyositis diagnosed after curative therapy for esophageal and oropharyngeal cancers
48. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
49. Second-line chemotherapy in patients with primary unknown cancer
50. A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.